Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease

NCT01178047 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped payments stopped by grant provider

Conditions

Parkinson's Disease

Interventions

DRUG: Rasagiline

Sponsor

University of Zurich

Collaborators

[object Object]